The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes

Hakonen, Elina; Varimo, Tero; Tuomaala, Anna‐Kaisa; Miettinen, Päivi J.; Pulkkinen, Mari‐Anne

doi:10.1186/s12887-022-03115-6

Cited by 17 publications

(17 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These data were confirmed in several other studies around the world [80,81]. The same conclusion was reached in different studies with children with T1DM, where the glycemic control did not deteriorate under the lockdown [82,83]. There are even studies showing an improvement in the glycemic control in T1DM children during confinement [84].…”

Section: Lockdown and Its Effect On Diabetessupporting

confidence: 80%

Diabetes and COVID-19: Short- and Long-Term Consequences

et al. 2022

View full text Add to dashboard Cite

When the corona pandemic commenced more than two years ago, it was quickly recognized that people with metabolic diseases show an augmented risk of severe COVID-19 and an increased mortality compared to people without these comorbidities. Furthermore, an infection with SARS-CoV-2 has been shown to lead to an aggravation of metabolic diseases and in single cases to new-onset metabolic disorders. In addition to the increased risk for people with diabetes in the acute phase of COVID-19, this patient group also seems to be more often affected by long-COVID and to experience more long-term consequences than people without diabetes. The mechanisms behind these discrepancies between people with and without diabetes in relation to COVID-19 are not completely understood yet and will require further research and follow-up studies during the following years. In the current review, we discuss why patients with diabetes have this higher risk of developing severe COVID-19 symptoms not only in the acute phase of the disease but also in relation to long-COVID, vaccine breakthrough infections and re-infections. Furthermore, we discuss the effects of lockdown on glycemic control.

show abstract

Section: Lockdown and Its Effect On Diabetessupporting

confidence: 80%

Diabetes and COVID-19: Short- and Long-Term Consequences

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Although the trends in recently published research are inconsistent, the majority indicated no deterioration or even an improvement in the management of T1DM patients during the COVID-19 pandemic [13,[19][20][21][22][23]. It is believed that telemedicine visits, use of advanced diabetes technologies (CGM, FGM, hybrid close loop), and improved self-care, as well as parental involvement, significantly contributed to better glycaemic control [15,24].…”

Section: Discussionmentioning

confidence: 99%

The incidence and causes of acute hospitalizations and emergency room visits in adolescents with type 1 diabetes mellitus prior to and during the COVID-19 pandemic: a single-centre experience

Nowak¹,

Gawlik²,

Wędrychowicz³

et al. 2023

pedm

View full text Add to dashboard Cite

Introduction: Type 1 diabetes mellitus (T1DM) is one of the most common chronic diseases in childhood. Because acute glycaemic complications account for most concerns in the management of T1DM in children, special attention during the challenging time of the global COVID-19 pandemic is required to prevent deteriorations resulting in acute hospitalization. Aim of the study is to assess how the COVID-19 pandemic influenced the incidence and causes of acute hospitalizations and emergency room visits in adolescents with established type 1 diabetes mellitus, and to characterize the admitted population. Material and methods:The study was conducted as a retrospective evaluation of acute hospitalizations of 39 T1DM patients between 15 and 17 years of age in the period 2018-2021. Results: No difference was noted in the incidence of acute hospitalizations and DKA or the biochemical parameters of adolescents with T1DM between the pre-COVID (23 patients in 2018-2019) and COVID period (16 patients in 2020-2021). It is, however, worth underlying that 6/11 (55%) patients hospitalised in 2021 experienced diabetes deterioration as a result of emotional distressa phenomenon that was not present in the pre-COVID era. After excluding of the hospitalizations due to psychosocial causes, a significant decrease in the number of acute hospitalizations in the COVID period was observed. Conclusions: We suppose that increased parental supervision during the pandemic might have prevented some of the episodes of severe disease decompensation, but this was masked by the sharp increase in hospitalizations due to emotional distress. Our data confirmed that psycho-emotional status is an important factor in the treatment of T1DM.

show abstract

“…A slight but significant improvement was found in many glucose metrics, during the lockdown period, with both treatments, thanks to telemedicine. In another study from Finland, conducted in children patients treated with insulin pumps, an improvement of their glucose control, showing in particular, significant amelioration of TIR and mean glucose values, was demonstrated during the lockdown, with respect to the pre-lockdown period [ 60 ]. T1D adults using the most sophisticated therapeutical approach, i.e.…”

Section: Telemedicine and Diabetes Management During Covid-19mentioning

confidence: 99%

Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience

Kreutzenberg

2022

High Blood Press Cardiovasc Prev

View full text Add to dashboard Cite

Telemedicine is a clinical approach that was seldom used in the day-to-day practice, if not only in certain settings, before the COVID-19 pandemic. As stated by the WHO, telemedicine is: the delivery of health care services, where distance is a critical factor, by all health care professionals using information and communication technologies (ICT) for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, …. Telemedicine has actually represented the most useful and employed tool to maintain contacts between patients and physicians during the period of physical distance imposed by the pandemic, especially during the lockdown. Diabetes in particular, a chronic disease that often needs frequent confronting between patient and health professionals has taken advantage of the telehealth approach. Nowadays, technological tools are more and more widely used for the management of diabetes. In this review results obtained by telemendicine application in type 1 and type 2 diabetic individuals during COVID-19 are revised, and future perspectives for telemedicine use to manage diabetes are discussed.

show abstract

The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes

Cited by 17 publications

References 22 publications

Diabetes and COVID-19: Short- and Long-Term Consequences

Diabetes and COVID-19: Short- and Long-Term Consequences

The incidence and causes of acute hospitalizations and emergency room visits in adolescents with type 1 diabetes mellitus prior to and during the COVID-19 pandemic: a single-centre experience

Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience

Contact Info

Product

Resources

About